Terray Therapeutics’ $120 Million Series B Funding

Leila Ahmed North America Legal Chronicle
Tagged:

Wilson Sonsini Goodrich & Rosati advised Terray on the transaction.Terray Therapeutics (Terray), a biotechnology company, announced raising $120 million in Series B funding round.  The funding…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here